Skip to main content

Table 2 Analysis of resistance level against antiretroviral drugs

From: HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China

Drug Drug resistance level
P
N (%)
L
N (%)
I
N (%)
H
N (%)
TDR
N (%)
PIs
 ATV 10 (0.87) 1 (0.09) 0 (0.00) 0 (0.00) 1 (0.09)
 DRV 0 (0.00) 2 (0.17) 0 (0.00) 0 (0.00) 2 (0.17)
 FPV 12 (1.04) 0 (0.00) 1 (0.09) 2 (0.17) 3 (0.26)
 IDV 11 (0.96) 1 (0.09) 0 (0.00) 0 (0.00) 1 (0.09)
 LPV 4 (0.35) 1 (0.09) 1 (0.09) 0 (0.00) 2 (0.17)
 NFV 8 (0.70) 10 (0.87) 3 (0.26) 0 (0.00) 13 (1.13)
 SQV 4 (0.35) 2 (0.17) 0 (0.00) 0 (0.00) 2 (0.17)
 TPV 3 (0.26) 7 (0.61) 0 (0.00) 0 (0.00) 7 (0.61)
NRTIs
 ABC 0 (0.00) 5 (0.43) 0 (0.00) 1 (0.09) 6 (0.52)
 AZT 3 (0.26) 4 0.35) 1 (0.09) 1 (0.09) 6 (0.52)
 D4T 1 (0.09) 7 (0.61) 2 (0.17) 0 (0.00) 9 (0.78)
 DDI 6 (0.52) 4 (0.35) 1 (0.09) 0 (0.00) 5 (0.43)
 FTC 2 (0.17) 0 (0.00) 1 (0.09) 3 (0.26) 4 (0.35)
 3TC 2 (0.17) 0 (0.00) 1 (0.09) 3 (0.26) 4 (0.35)
 TDF 0 (0.00) 2 (0.17) 0 (0.00) 1 (0.09) 3 (0.26)
NNRTIs
 DOR 1 (0.09) 31 (2.69) 0 (0.00) 2 (0.17) 33 (2.87)
 EFV 137 (11.90) 5 (0.43) 4 (0.35) 3 (0.26) 12 (1.04)
 ETR 173 (15.03) 6 (0.52) 4 (0.35) 0 (0.00) 10 (0.87)
 NVP 162 (14.07) 6 (0.52) 2 (0.17) 6 (0.52) 14 (1.22)
RPV 158 (13.73) 19 (1.65) 5 (0.43) 1 (0.09) 25 (2.17)
  1. P potential resistance, L low resistance, I intermediate resistance, H high resistance, ATV atazanavir, DRV darunavir, FPV fosamprenavir, IDV indinavir, LPV Kaletra, NFV nelfinavir, SQV saquinavir, TPV tipranavir, ABC abacavir, AZT zidovudine, D4T stavudine, DDI didanosine, FTC emtricitabine, 3TC lamivudine, TDF tenofovir, DOR doravirine, EFV efavirenz, ETR etravirine, NVP nevirapine, RPV rilpivirine. Drug resistance = L + I + H